Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
By T. Foster. FEMS Microbiology Reviews, 2017
741 citations recorded by the source corpus.
Subfields: Infectious Diseases, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/bfb244e57951ac09d41087263797ad0ec9cc4cd3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yunlei Guo
- Juan Wang
- Moushumi Tabassoom Salam
- Guanghui Song
- Meiling Sun
- Yi Wang
- M. Al-Amin
- M. Salam
Citations in the corpus
- Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus (2020, background): “Through plasmid-mediated transduction, transformation, and insertion of drug-resistant genes, excessive β-lactamase can be produced, leading to bacteria resistance (Foster, 2017; Haaber et al., 2017).”
- Antibiotic resistance and persistence—Implications for human health and treatment perspectives (2020, neutral): “There are many excellent reviews already published focusing on antibiotic resistance (Turnidge & Christiansen, 2005; Spellberg et al , 2013; Blair et al , 2015; Foster, 2017; Rather et al , 2017; Zaman et al , 2017; Aslam et al , 2018; Jorge et al , 2019; Lopez-Jacome et al , 2019).”
- Antimicrobial Resistance: A Growing Serious Threat for Global Public Health (2023, background): “exhibits a significant reduction in its affinity to β-lactam antibiotics due to an alternative penicillin-binding protein encoded by mecA and mecC genes [45,46].”